Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: A report from the childhood cancer survivor study Journal Article


Authors: Mueller, S.; Fullerton, H. J.; Stratton, K.; Leisenring, W.; Weathers, R. E.; Stovall, M.; Armstrong, G. T.; Goldsby, R. E.; Packer, R. J.; Sklar, C. A.; Bowers, D. C.; Robison, L. L.; Krull, K. R.
Article Title: Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: A report from the childhood cancer survivor study
Abstract: Purpose: To test the hypotheses that (1) the increased risk of stroke conferred by childhood cranial radiation therapy (CRT) persists into adulthood; and (2) atherosclerotic risk factors further increase the stroke risk in cancer survivors. Methods and Materials: The Childhood Cancer Survivor Study is a multi-institutional retrospective cohort study of 14,358 5-year survivors of childhood cancer and 4023 randomly selected sibling controls with longitudinal follow-up. Age-adjusted incidence rates of self-reported late-occurring (≥5 years after diagnosis) first stroke were calculated. Multivariable Cox proportional hazards models were used to identify independent stroke predictors. Results: During a mean follow-up of 23.3 years, 292 survivors reported a late-occurring stroke. The age-adjusted stroke rate per 100,000 person-years was 77 (95% confidence interval [CI] 62-96), compared with 9.3 (95% CI 4-23) for siblings. Treatment with CRT increased stroke risk in a dose-dependent manner: hazard ratio 5.9 (95% CI 3.5-9.9) for 30-49 Gy CRT and 11.0 (7.4-17.0) for 50+ Gy CRT. The cumulative stroke incidence in survivors treated with 50+ Gy CRT was 1.1% (95% CI 0.4-1.8%) at 10 years after diagnosis and 12% (95% CI 8.9-15.0%) at 30 years. Hypertension increased stroke hazard by 4-fold (95% CI 2.8-5.5) and in black survivors by 16-fold (95% CI 6.9-36.6). Conclusion: Young adult pediatric cancer survivors have an increased stroke risk that is associated with CRT in a dose-dependent manner. Atherosclerotic risk factors enhanced this risk and should be treated aggressively. © 2013 Elsevier Inc.
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 86
Issue: 4
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2013-07-15
Start Page: 649
End Page: 655
Language: English
DOI: 10.1016/j.ijrobp.2013.03.034
PROVIDER: scopus
PMCID: PMC3696633
PUBMED: 23680033
DOI/URL:
Notes: --- - "Export Date: 1 July 2013" - "CODEN: IOBPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles A Sklar
    322 Sklar